AG˹ٷ

STOCK TITAN

[Form 4] STERIS plc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

STERIS plc director Shah Nirav R reported insider transactions on 08/08/2025 showing a grant of 1,407 nonqualified stock options with a $242.85 exercise price and an expiration date of 08/08/2035. The filing states these options are fully vested and exercisable immediately. The report also shows 487 Career Restricted Stock Units that are fully vested and will be settled in ordinary shares six months after the cessation of the director's board service. The filing records 1,407 options and 6,503 derivative securities beneficially owned following the reported transactions.

Il consigliere di STERIS plc, Shah Nirav R, ha segnalato operazioni interne in data 08/08/2025 che indicano la concessione di 1,407 opzioni su azioni non qualificate con prezzo di esercizio di $242.85 e scadenza il 08/08/2035. Il documento dichiara che queste opzioni sono interamente maturate ed esercitabili immediatamente. Il rapporto riporta inoltre 487 Career Restricted Stock Units, pienamente maturate e che saranno liquidate in azioni ordinarie sei mesi dopo la cessazione del mandato del consigliere nel consiglio di amministrazione. Dopo le operazioni segnalate il deposito registra la titolarità beneficiaria di 1,407 opzioni e di 6,503 strumenti derivati.

El miembro del consejo de STERIS plc, Shah Nirav R, informó transacciones de insider el 08/08/2025 que muestran la concesión de 1,407 opciones sobre acciones no calificadas con precio de ejercicio de $242.85 y vencimiento el 08/08/2035. El expediente indica que estas opciones están totalmente adquiridas y son ejercitables de inmediato. El informe también muestra 487 Career Restricted Stock Units que están totalmente adquiridas y se liquidarán en acciones ordinarias seis meses después de la finalización del cargo del consejero en el consejo. Tras las operaciones notificadas, el registro refleja la titularidad beneficiaria de 1,407 opciones y de 6,503 valores derivados.

STERIS plc� 이사 Shah Nirav R� 08/08/2025� 내부자거래를 보고했으�, 보고서에� 행사 가격이 $242.85이고 만료일이 08/08/20351,407개의 비자� 스톡옵션(nonqualified stock options)� 부여된 것으� 나와 있습니다. 제출서류� � 옵션들이 전액 베스팅되� 즉시 행사 가능하다고 명시합니�. 보고서에� 또한 전액 베스팅된 487개의 Career Restricted Stock Units가 기재되어 있으�, 이들은 이사가 이사회직� 떠난 � 6개월 이내� 보통주로 정산� 예정입니�. 보고� 거래 이후 해당 제출서류� 1,407개의 옵션� 6,503개의 파생증권� 실질적으� 보유하고 있음� 기록하고 있습니다.

L'administrateur de STERIS plc, Shah Nirav R, a déclaré des opérations d'initiés le 08/08/2025 faisant état de l'attribution de 1,407 options d'achat d'actions non qualifiées au prix d'exercice de $242.85 et expirant le 08/08/2035. Le dépôt précise que ces options sont entièrement acquises et exerçables immédiatement. Le rapport indique également 487 Career Restricted Stock Units, entièrement acquises et qui seront réglées en actions ordinaires six mois après la cessation des fonctions de l'administrateur au conseil. Après les transactions déclarées, le dépôt enregistre la détention bénéficiaire de 1,407 options et de 6,503 instruments dérivés.

Der Direktor von STERIS plc, Shah Nirav R, meldete Insidergeschäfte am 08/08/2025, die die Gewährung von 1,407 nichtqualifizierten Aktienoptionen mit einem Ausübungspreis von $242.85 und einem Verfallsdatum am 08/08/2035 ausweisen. Die Meldung gibt an, dass diese Optionen vollständig unverfallbar sind und sofort ausgeübt werden können. Der Bericht weist außerdem 487 Career Restricted Stock Units aus, die vollständig unverfallbar sind und sechs Monate nach Beendigung der Tätigkeit des Direktors im Vorstand in Stammaktien abgewickelt werden. Nach den gemeldeten Transaktionen verzeichnet die Einreichung den wirtschaftlichen Besitz von 1,407 Optionen und 6,503 Derivaten.

Positive
  • Options are fully vested and exercisable immediately, providing clear rights to the reporting person.
  • Career Restricted Stock Units are fully vested and include explicit settlement timing (six months after board service ends).
Negative
  • None.

Insights

TL;DR: Routine director equity grants; options vested immediately, RSUs settle after board service ends.

The Form 4 discloses a director-level equity award package executed on 08/08/2025. Key specifics: 1,407 nonqualified stock options at an exercise price of $242.85 expiring 08/08/2035, and 487 Career Restricted Stock Units that are fully vested and convert to ordinary shares six months after board service termination. The options are explicitly stated as fully vested and exercisable immediately, which is material to near-term insider liquidity but is a standard governance compensation action.

TL;DR: Disclosure reflects standard director compensation with clear vesting and settlement terms.

The filing identifies the reporting person as Shah Nirav R in the role of Director. The Career RSUs include a delayed settlement condition: they will be settled in ordinary shares six months after the director leaves the board. The Form 4 is signed via authorized representative on 08/12/2025. The disclosure provides transparent timelines and amounts for equity awards, enabling shareholders to track potential future share issuance tied to RSU settlement conditions.

Il consigliere di STERIS plc, Shah Nirav R, ha segnalato operazioni interne in data 08/08/2025 che indicano la concessione di 1,407 opzioni su azioni non qualificate con prezzo di esercizio di $242.85 e scadenza il 08/08/2035. Il documento dichiara che queste opzioni sono interamente maturate ed esercitabili immediatamente. Il rapporto riporta inoltre 487 Career Restricted Stock Units, pienamente maturate e che saranno liquidate in azioni ordinarie sei mesi dopo la cessazione del mandato del consigliere nel consiglio di amministrazione. Dopo le operazioni segnalate il deposito registra la titolarità beneficiaria di 1,407 opzioni e di 6,503 strumenti derivati.

El miembro del consejo de STERIS plc, Shah Nirav R, informó transacciones de insider el 08/08/2025 que muestran la concesión de 1,407 opciones sobre acciones no calificadas con precio de ejercicio de $242.85 y vencimiento el 08/08/2035. El expediente indica que estas opciones están totalmente adquiridas y son ejercitables de inmediato. El informe también muestra 487 Career Restricted Stock Units que están totalmente adquiridas y se liquidarán en acciones ordinarias seis meses después de la finalización del cargo del consejero en el consejo. Tras las operaciones notificadas, el registro refleja la titularidad beneficiaria de 1,407 opciones y de 6,503 valores derivados.

STERIS plc� 이사 Shah Nirav R� 08/08/2025� 내부자거래를 보고했으�, 보고서에� 행사 가격이 $242.85이고 만료일이 08/08/20351,407개의 비자� 스톡옵션(nonqualified stock options)� 부여된 것으� 나와 있습니다. 제출서류� � 옵션들이 전액 베스팅되� 즉시 행사 가능하다고 명시합니�. 보고서에� 또한 전액 베스팅된 487개의 Career Restricted Stock Units가 기재되어 있으�, 이들은 이사가 이사회직� 떠난 � 6개월 이내� 보통주로 정산� 예정입니�. 보고� 거래 이후 해당 제출서류� 1,407개의 옵션� 6,503개의 파생증권� 실질적으� 보유하고 있음� 기록하고 있습니다.

L'administrateur de STERIS plc, Shah Nirav R, a déclaré des opérations d'initiés le 08/08/2025 faisant état de l'attribution de 1,407 options d'achat d'actions non qualifiées au prix d'exercice de $242.85 et expirant le 08/08/2035. Le dépôt précise que ces options sont entièrement acquises et exerçables immédiatement. Le rapport indique également 487 Career Restricted Stock Units, entièrement acquises et qui seront réglées en actions ordinaires six mois après la cessation des fonctions de l'administrateur au conseil. Après les transactions déclarées, le dépôt enregistre la détention bénéficiaire de 1,407 options et de 6,503 instruments dérivés.

Der Direktor von STERIS plc, Shah Nirav R, meldete Insidergeschäfte am 08/08/2025, die die Gewährung von 1,407 nichtqualifizierten Aktienoptionen mit einem Ausübungspreis von $242.85 und einem Verfallsdatum am 08/08/2035 ausweisen. Die Meldung gibt an, dass diese Optionen vollständig unverfallbar sind und sofort ausgeübt werden können. Der Bericht weist außerdem 487 Career Restricted Stock Units aus, die vollständig unverfallbar sind und sechs Monate nach Beendigung der Tätigkeit des Direktors im Vorstand in Stammaktien abgewickelt werden. Nach den gemeldeten Transaktionen verzeichnet die Einreichung den wirtschaftlichen Besitz von 1,407 Optionen und 6,503 Derivaten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shah Nirav R

(Last) (First) (Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)
DUBLIN 2 L2 D02 R296

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Stock Option (right to buy) $242.85 08/08/2025 A 1,407 (1) 08/08/2035 Ordinary Shares 1,407 $0 1,407 D
Career Restricted Stock Units (2) 08/08/2025 A 487 (3) (3) Ordinary Shares 487 $0 6,503 D
Explanation of Responses:
1. These nonqualified stock options are fully vested and are exercisable immediately.
2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Shah Nirav R report on Form 4 for STERIS (STE)?

The Form 4 reports a grant of 1,407 nonqualified stock options and 487 Career Restricted Stock Units, both reported with a transaction date of 08/08/2025.

What are the terms of the stock options reported on the Form 4?

The options have an exercise price of $242.85, are stated as fully vested and exercisable immediately, and expire on 08/08/2035.

When will the reported Career Restricted Stock Units (RSUs) be settled?

Each Career RSU converts to one ordinary share and will be settled six months after the cessation of the director's board service; the RSUs are reported as fully vested.

How many derivative securities are reported as beneficially owned after the transactions?

The filing shows 1,407 derivative securities for the stock options and 6,503 derivative securities beneficially owned following the reported transactions.

Who filed the Form 4 and when was it signed?

The reporting person is Shah Nirav R identified as a Director. The form is signed by an authorized representative on 08/12/2025.
Steris Plc

NYSE:STE

STE Rankings

STE Latest News

STE Latest SEC Filings

STE Stock Data

23.92B
98.18M
0.3%
95.58%
0.86%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
DUBLIN